NCT03562897 2022-07-06
Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer
Catalysis SL
Phase 2 Completed
Catalysis SL
National Institutes of Health Clinical Center (CC)
National Cancer Institute, Slovakia
Royan Institute